科学研究 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine
The Year in Cardiovascular Medicine 2020: Coronary Intervention
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T
Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology
Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review
Cardiorespiratory Fitness and Mortality in Healthy Men and Women
Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown Unknowns
Cholesterol-Lowering Agents
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials

|<<... 62 63 64 65 66 67 68 ...>>|

Review Article

2018;138:2841–2851

JOURNAL：Circulation.

Article Link

Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine

JJ Han, MA Acker, P Atluri et al.

15369

Keywords: left ventricular assist device; heart failure; suck-down event; park stitch; HMIII artificial pulsatility; hemocompatability; quality-adjusted life years; incremental cost-effectiveness ratio

FULL TEXT PDF